Items where authors include "Vaknin, I."

Article

De Lorenzis, E. orcid.org/0000-0001-9819-105X, Mor, A., Ross, R.L. et al. (4 more authors) (2024) Serum CCL24 as a biomarker of fibrotic and vascular disease severity in Systemic Sclerosis. Arthritis Care & Research, 76 (9). pp. 1269-1277. ISSN 2151-464X

Conference or Workshop Item

Del Galdo, F. orcid.org/0000-0002-8528-2283, Khanna, D., Crater, C. et al. (6 more authors) (2023) AB0808 a proof of biological concept trial of CM101 to target CCL24 in systemic sclerosis: a biomarker informed, precision medicine approach. In: EULAR 2023 European Congress of Rheumatology, 31 May - 03 Jun 2023, Milan, Italy.

Proceedings Paper

De Lorenzis, E., Mor, A., Ross, R. et al. (5 more authors) (2023) CCL24 serum concentration predicts both vascular and fibrotic complications in systemic sclerosis. In: Annals of the Rheumatic Diseases. EULAR 2023 European Congress of Rheumatology, 31 May - 03 Jun 2023, Milan, Italy. BMJ Publishing Group , p. 971.

De Lorenzis, E., Mor, A., Ross, R. et al. (5 more authors) (2023) OA28 CCL24 serum concentration predicts both vascular and fibrotic complications in systemic sclerosis: rationale for a biological target driven basket trial across disease subsets. In: Rheumatology. British Society for Rheumatology Annual Conference 2023, 24-26 Apr 2023, Manchester, UK. Oxford University Press .